US Broker Ratings

LifeStance Health Group, Inc. (LFST) Stock Analysis: Strong Buy Ratings Signal 21% Potential Upside

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the U.S. healthcare sector, is capturing investor attention with its robust growth prospects and dominant position..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a 19% Downside in Biotech’s Promising Frontier

Metsera, Inc. (MTSR), a clinical-stage biotechnology company based in New York, is at the forefront of developing innovative therapies targeting obesity and related disorders. Despite its..

Privia Health Group, Inc. (PRVA) Stock Analysis: Riding a 29.51% Potential Upside Wave

Privia Health Group, Inc. (NASDAQ: PRVA) is making waves in the healthcare sector with its innovative approach to physician enablement and value-based care. As a national..

Alvotech (ALVO) Stock Analysis: Unveiling a Striking 352% Potential Upside

Alvotech (ALVO), a prominent player in the healthcare sector specializing in biosimilar medicines, is capturing the attention of investors with its staggering potential upside. Based in..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 36.45% Potential Upside Captivates Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has been catching the eye of investors, particularly with the enticing potential upside of 36.45%, as indicated by analysts’ average target..

Denali Therapeutics Inc. (DNLI) Stock Analysis: A Biotech Powerhouse with 101% Upside Potential

Denali Therapeutics Inc. (NASDAQ: DNLI) is making waves in the biotechnology sector with its ambitious pipeline targeting some of the most challenging neurodegenerative and lysosomal storage..

Zai Lab Limited (ZLAB): Investor Outlook on a Biotech Powerhouse with a Promising 171% Upside

Investors keeping an eye on the biotechnology sector should not overlook Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the healthcare industry. With a market..

Organon & Co. (OGN) Stock Analysis: Exploring the 25.77% Potential Upside for Investors

Investors on the lookout for opportunities in the healthcare sector may find Organon & Co. (NYSE: OGN) an intriguing prospect. With a market capitalization of $1.93..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: A Deep Dive into 71% Upside Potential

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is capturing investor attention with its significant upside potential, evident in the latest analyst ratings that suggest a possible 71.08% increase..

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Navigating a 40.73% Potential Upside in the Biotech Space

Apellis Pharmaceuticals, Inc. (APLS), a prominent player in the biotechnology industry, continues to capture investor attention with its strategic focus on novel therapeutic compounds. Based in..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 48.20% Upside with a High Dividend Yield

Perrigo Company plc (NASDAQ: PRGO) stands as a significant player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Dublin,..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating Challenges with a Promising Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, specializing in medical instruments and supplies, is currently attracting attention with its compelling dividend..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 65.94% Upside Potential Amid Sector Growth

Surgery Partners, Inc. (NASDAQ: SGRY) has emerged as an intriguing proposition for investors eyeing the healthcare sector. With its strategic focus on surgical facilities and ancillary..

Viking Therapeutics, Inc. (VKTX): Biotech Stock with a 190% Upside Potential – An Investor’s Insight

Viking Therapeutics, Inc. (NASDAQ: VKTX) has been capturing the attention of investors in the biotech sector, thanks to its ambitious drug development pipeline and the potential..

LivaNova PLC (LIVN) Stock Analysis: Exploring a Potential 11.71% Upside in Medical Devices

As the healthcare sector continues to play a pivotal role in global economies, LivaNova PLC (NASDAQ: LIVN) stands out as a noteworthy player in the medical..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in the Dental Industry

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, is capturing investor interest with its focus on dental products. Operating primarily within the..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: Biotechnology Innovator with a Promising 12% Upside

In the dynamic and often volatile world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out for its innovative approach to tackling serious diseases. With..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Navigating Growth with a 43.5% Revenue Surge

Alignment Healthcare, Inc. (NASDAQ: ALHC) is making waves in the healthcare sector with its innovative approach to senior care through Medicare Advantage plans. With a market..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating the Biotech Frontier with a 6.64% Potential Upside

In the ever-evolving landscape of biotechnology, PTC Therapeutics, Inc. (NASDAQ: PTCT) stands out as a significant player. With its focus on rare disorders, the company is..

Haemonetics Corporation (HAE) Stock Analysis: Insights into a Promising Medical Device Leader with a 9.85% Upside

Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $3.96 billion,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds